1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Bladder Pain Syndrome: new trials by email Literature Review of Bladder Pain Syndrome trials Research Report on Bladder Pain Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions Neovasculgen®, Placebo - IC, Hunner Type Interstitial Cystitis | Phase 2 / Phase 3 | Recruiting | JSC NextGen | 180 | 2023-12-29 | 2026-03-10 |
| A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain Multimodal Bundle Drugs, Operative Cystoscopy, Behavioral health consultation/therapy - Interstitial Cystitis, Levator Spasm | Phase 3 | Terminated | Jocelyn Fitzgerald | 26 | 2022-12-06 | 2026-04-01 |
| Clinical Trial Comparing Two Bladder Instillations for IC/BPS Bladder instillation WITH triamcinolone acetonide, Bladder instillation WITHOUT triamcinolone acetonide - Interstitial Cystitis, Bladder Pain Syndrome | Phase 3 | Completed | Olivia Cardenas-Trowers, M.D. | 90 | 2019-01-25 | 2021-09-01 |
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome AQX-1125 100 mg, AQX-1125 200 mg, Placebo - Interstitial Cystitis, Bladder Pain Syndrome | Phase 3 | Unknown | Aquinox Pharmaceuticals (Canada) Inc. | 433 | 2016-07-01 | 2018-03-15 |
Cystitis, Interstitial (4) · Pelvic Pain (1)
Cystitis (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Urinary Bladder Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Administration, Intravesical (2) · 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (1) · Amitriptyline (1) · Gabapentin (1) · Methenamine (1) · Therapeutics (1) · Triamcinolone Acetonide (1)
Aquinox Pharmaceuticals (Canada) Inc. (1) · JSC NextGen (1) · Jocelyn Fitzgerald (1) · Olivia Cardenas-Trowers, M.D. (1)
United States (3) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Hungary (1) · Latvia (1) · Netherlands (1) · Poland (1) · Romania (1) · Russia (1) · Spain (1) · United Kingdom (1)
Jocelyn J Fitzgerald, MD (1) · Olivia Cardenas-Trowers, M.D. (1) · Robert Moldwin, MD (1) · Sean Francis, M.D. (1)